Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction

A phosphodiesterase and inhibitor technology, which can be applied to medical preparations containing active ingredients, digestive system, organic active ingredients, etc. Learning and memory, high inhibitory activity

Active Publication Date: 2014-02-12
LAMSON PHARM (SUZHOU) CO
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The first generation of PDE4 inhibitors such as rolipram has a good antidepressant effect, the reason why it cannot be marketed is the side effects such as nausea and vomiting caused by the inhibition of PDE4
Compared with the first-generation PDE4 inhibitors, the second-generation PDE4 inhibitors have better therapeutic effects, but so far no PDE4 inhibitors that can prevent vomiting have been marketed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction
  • Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction
  • Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] Embodiments of the present invention will be described in further detail below in conjunction with the accompanying drawings.

[0031] A kind of phosphodiesterase 4 inhibitor that can avoid vomiting reaction, wherein, by formula (I) as

[0032]

[0033] Representative compounds or prodrugs or solvates,

[0034] R 1 are independently methoxy, bromo and substituted aryl;

[0035] X is an optionally substituted six-membered heterocyclic ring;

[0036] Y is - (CH 2 ) n -, -NH(CH 2 ) n -, -NH(CH 2 ) n -O-, wherein, the value of n can be any one digit in 0, 1, 2, 3;

[0037] Z is an optionally substituted aryl ring or an optionally substituted heteroaryl ring.

[0038] The above-mentioned formula (II) is

[0039]

[0040] Representative compounds or prodrugs or pharmaceutically acceptable salts or solvates;

[0041] Wherein: Z is any substituted aromatic ring.

[0042] The above-mentioned formula (III) is

[0043]

[0044] Representative compounds or pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a kind of Phosphodiesterase 4 inhibitors without vomiting, which is compounds or a prodrugs or solvates represented by formula (I), R 1 is an independent methoxy, bromine and substituted aryl; X is an optionally substituted six-membered heterocyclic ring; Y is -(CH 2 ) n -, -NH(CH 2 ) n -, and-NH(CH 2 ) n -O-, wherein n is any value among 0, 1, 2 and 3; Z is an optionally substituted aromatic ring or an optionally substituted heteroaromatic ring. The present invention is relates to a kind of Phosphodiesterase 4 inhibitors without vomiting, which is a novel biphenyl series PDE4D inhibitor, and can be applied to treat depression and Alzheimer's disease, improve cognitive ability and avoid vomiting.

Description

technical field [0001] The present invention relates to the technical field of compounds capable of inhibiting phosphodiesterase, especially a biphenyl PDE4D inhibitor, specifically a phosphodiesterase 4 inhibitor capable of avoiding vomiting. Drugs can be used to treat depression, Alzheimer's disease and improve cognition. Background technique [0002] Phosphodiesterase 4 (PDE4) is mainly distributed in inflammatory cells (mast cells, macrophages, lymphocytes and epithelial cells) and nerve cells. PDE4 is closely related to the functions of the central nervous system and the immune system, and its inhibitors are considered to be new anti-inflammatory drugs and central nervous system drug candidates acting on intracellular targets. Since PDE4 specifically catalyzes the hydrolysis of cAMP, it plays a key role in regulating the concentration of intracellular cAMP. Inhibiting PDE4 causes cAMP to accumulate in cells and produce various biological effects, including anti-inflamm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D295/096C07D237/14C07D237/22A61K31/495A61K31/50A61K31/501A61P25/24A61P25/28
CPCC07D237/14C07D237/02A61K31/495C07D403/04C07D295/096C07D237/22C07D295/04A61K31/496A61K31/501A61K31/50C07D295/092A61P1/08A61P25/24A61P25/28A61P43/00
Inventor 徐江平周中振
Owner LAMSON PHARM (SUZHOU) CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com